IBio Analyst Ratings
Benzinga Analyst RatingsFeb 16, 2023 05:08 ET
IBio Analyst Ratings
Benzinga Analyst RatingsOct 7, 2022 05:22 ET
Cantor Fitzgerald Downgrades IBio to Neutral, Lowers Price Target to $0.17
Benzinga Real-time NewsOct 7, 2022 05:21 ET
No Data
No Data